Microba Life Sciences Ltd News Today

Microba Life Sciences Ltd (ASX:MAP) CEO Dr Luke Reid speaks to Proactives Thomas Warner about the companys work in developing gut microbiome testing...

Microba Life Sciences Limited lists on the ASX today under code MAP after raising $30 million. The market capitalisation is ~$123 million (on an undiluted basis) at the Offer price of $0.45 per share.Microba is a commercial-stage company delivering gut microbiome testing services globally and driving the discovery o...